A clinical trial to study the effect of an ayurvedic mineral drug in 30 patients with primary insomnia

Clinical study of swarnamakshika bhasma in Anidra (Primary Insomnia)

Status

Recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/10/010070

Enrollment

Registered

2017-10-12

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- PRIMARY INSOMINA

Interventions

Intervention1: Swarna makshika bhasma 250 mg orally for 30 days: 30 patients who will be screened and fullfilled the inclusion criteria will be given 20 mg of swarna makshika bhasma orally at night wi

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion criteria 1 Diagnosed case of primary insomnia complaining of Angamarda Shirogaurava Jrumbha Jadyata Glani Bhrama Apakti 2 Age group between 20-50 years 3 Patients of both gender irrespective of socio-economic status 4 Patients with mild hypertension 5 Patients ready to sign informed consent form

Exclusion criteria

Exclusion criteria: Exclusion criteria 1 Insomnia due to substance abuse or trauma 2 Physiological conditions like pregnancy lactation and puerperal stage

Design outcomes

Primary

Measure	Time frame
Insomnia severity index scale will be used before and after treatmentTimepoint: 30 Days	—

Secondary

Measure	Time frame
Quality of life will be assessedTimepoint: 30 Days	—

Countries

India

Contacts

Public ContactDr Suhas kumar shetty

Sri Dharmasthala Manjunatheshwara colege of ayurveda and hospital hassan

drsuhasshetty@gmail.com9449603234

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026